US drug regulator clears Qnovia’s nicotine inhaler for clinical testing
HQ Team October 7, 2024: The US Food and Drug Administration (FDA)has cleared Qnovia Inc’s nicotine inhaler RespiRx for clinical trial. The US.
Drugs
Health
Pharma
Drugs
Health
Medical
AstraZeneca in $1.92 million deal with HK-listed CSPC Pharmaceutical
British-Swedish AstraZeneca signed a $1.92 billion licensing agreement with CSPC Pharmaceutical Group to develop, manufacture and commercialize a compound to treat a metabolic.
Climate
Health
Medical
Vegetation cover in Antarctic Peninsula increases 10-fold in last four yrs: Study
Extreme warming in the Antarctic Peninsula has increased the vegetation cover in the region by more than tenfold over the last four decades,.
Drugs
Health
Medical
Congo begins mpox vaccination in eastern region, roll-outs in 11 provinces
he Democratic Republic of the Congo has started mpox vaccination aiding efforts to halt the spread of the viral disease, according to the.
Climate
Health
Pharma
More than 200 land defenders died globally in 2023, Colombia deadliest
More than 200 people were murdered worldwide last year while trying to protect their lands and the environment from corporations, governments and non-state.
Drugs
Health
Pharma
Johnson & Johnson stops mid-stage trial of drug for dengue prevention
Johnson & Johnson has discontinued its mid-stage trial, evaluating an antiviral drug, mosnodenvir, for the prevention of dengue.
Drugs
Health
Pharma
Recordati buys Sanofi’s drug for autoimmune disease for $825 million
Italy’s Recordati will acquire global rights for Sanofi’s drug Enjaymo, used in the treatment of a rare autoimmune disease that causes the body's.
Drugs
Health
Pharma
EMA starts review of medicines to treat hair loss, prostate enlargement
The European Medicines Agency is reviewing two medicines meant to treat hair loss and prostate enlargement following concerns regarding suicidal ideation and behaviours.
Drugs
Health
Pharma
UK scientists receive funding to develop world’s first ovarian cancer vaccine
HQ Team October 4, 2024: Researchers at the University of Oxford have received £600,000 (€719,960) from Cancer Research UK to fund their project.